---
title: "Morgan Stanley: Raises MicroPort Medbot-W installation forecast, target price increased to HKD 42"
description: "JP Morgan released a research report stating that it has raised the target price for MicroPort Medbot-B from HKD 30.9 to HKD 42, valuing it based on discounted cash flow rates. The investment rating i"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/261018069.md"
published_at: "2025-10-14T09:01:02.000Z"
---

# Morgan Stanley: Raises MicroPort Medbot-W installation forecast, target price increased to HKD 42

> JP Morgan released a research report stating that it has raised the target price for MicroPort Medbot-B from HKD 30.9 to HKD 42, valuing it based on discounted cash flow rates. The investment rating is "Overweight," reaffirming the stock as the top choice among Chinese medical technology stocks, and indicating that the recent price pullback presents a good buying opportunity given that the fundamental factors remain unchanged. MicroPort Medbot's global order momentum remains strong, with over 170 surgical robot orders accumulated as of last Wednesday (the 8th), up from 150 at the end of August. The report noted that the installation of Toumai (four-arm laparoscopic surgical robot) is accelerating globally, with rapid international expansion, applied in nearly 40 countries and major hospital systems, driving strong adoption. The bank has raised its forecast for the number of installations completed this year from 84 to 105, primarily due to growth overseas and the assumption that orders can be converted into sales within less than a quarter, based on approximately 100 cumulative orders for Toumai. There is an expectation of improved installation volume and product mix, as well as an anticipated gross margin improvement of 1 to 1.5 percentage points

According to Zhitong Finance APP, JP Morgan has released a research report stating that it has raised the target price for MicroPort Medbot-B (02252) from HKD 30.9 to HKD 42. This valuation is based on the discounted cash flow rate, with an investment rating of "Overweight," reaffirming that this stock is the top choice among Chinese medical technology stocks, and indicating that the recent price pullback presents a good buying opportunity given that the fundamental factors remain unchanged.

MicroPort Medbot's global order momentum remains strong, with over 170 surgical robot orders accumulated as of last Wednesday (the 8th), up from 150 at the end of August. The report indicates that the installation of Toumai (four-arm laparoscopic surgical robot) is accelerating globally, with rapid international expansion, applied in nearly 40 countries and major hospital systems, driving strong adoption.

Based on approximately 100 cumulative orders for Toumai, the bank has raised its forecast for the number of installations completed this year from 84 to 105, primarily due to growth overseas and the assumption that orders can be converted into sales within less than a quarter. There is a higher installation base and product mix improvement, along with an expected gross margin improvement of 1 to 1.5 percentage points

### Related Stocks

- [02252.HK - MircroPort Medbot-B](https://longbridge.com/en/quote/02252.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 港股异动：微创机器人-B 大涨 20.09%，新产品获批与订单激增提振市场信心 | 微创机器人-B 大涨 20.09%；微创医疗涨 3.39%，成交额达到 1.1 亿港币；微创脑科学涨 3.29%，成交额达到 18.2 百万港币；先健科技成交额达到 7.63 百万港币；时代天使跌 0.49%，市值达到 103 亿港币。 | [Link](https://longbridge.com/en/news/270940812.md) |
| 国产手术机器人，走到哪一步了？ | 浙商证券研报称，随着医保局收费目录政策落地和海外市场加速拓展，行业有望从早期发展期步入快速增长期。2026 年医保局收费目录政策落地，明确四类机器人收费框架，将显著降低入院门槛。微创、精锋等头部企业海外订单快速增长，出海成新引擎。预计到 2 | [Link](https://longbridge.com/en/news/273490886.md) |
| 人形机器人狂奔 2026：谁为盛宴买单？ | 一场从实验室走向 “预算表” 的战略迁移。 | [Link](https://longbridge.com/en/news/276190649.md) |
| 对话松延动力创始人姜哲源：从亮相春晚到「要规模」 | 2026 年机器人大战 | [Link](https://longbridge.com/en/news/276060330.md) |
| 谷歌高层回应 AI 泡沫质疑：这是工业革命，但速度快 10 倍、规模大 10 倍 | 谷歌 CEO 在印度 AI 峰会上透露谷歌云积压订单已翻倍至 2400 亿美元，以此证明高额资本开支的合理性。DeepMind CEO 预测实现通用人工智能至少仍需 5-10 年。谷歌高层一致认为，AI 将从根本上改变中小企业和科学研究的工 | [Link](https://longbridge.com/en/news/276440500.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.